ICCM Share Price Performance
US$0.87
0.31 (54.44%)
Price US$0.87
Share PriceUS$0.87
Shareholders May Find It Hard To Justify Increasing IceCure Medical Ltd's (NASDAQ:ICCM) CEO Compensation For Now
Aug 14
IceCure Medical Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
ICCM Community Narratives
There are no narratives available yet.
IceCure Medical Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.23
- Gross Margin
- 35.92%
- Net Profit Margin
- -559.02%
- Debt/Equity Ratio
- 69.5%
IceCure Medical Ltd Competitors
Snowflake Analysis
About ICCM
- Founded
- 2006
- Employees
- 65
- CEO
- WebsiteView website
IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Israeli Market Performance
- 7 Days: 3.4%
- 3 Months: 4.3%
- 1 Year: 65.3%
- Year to Date: 36.3%
The market is up 3.4% in the last 7 days, led by the Real Estate and all sectors gaining ground. The market is up 65% over the last 12 months. Earnings are forecast to grow by 16% annually. Market details ›